Health Friday 1.9.2026 Open Thread: The Baric Files, Part Four: EcoHealth Alliance; Wuhan Institute of Virology; Dr. Zheng-li Shi; the “Template Patent”

The vintage image of laundering for the featured image today is courtesy of Google Images.

Health Friday is a series devoted to Big Pharma, vaccines, general health, and associated topics. As today’s offering (as are all the posts of The Baric Files) is related to the lab-creation of the SARS-CoV-2 (COVID-19) virus, Yours Truly dedicates it all persons, of whatever age or location, who have suffered an infection of this virus and recovered (with or without post-infection-induced complications); or, who have died from complications resulting from, or associated with, a COVID-19 virus infection.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated content. To the best of her knowledge and belief, there is none, except perhaps for AI-generated images and/or text within linked URLs.

Special Note regarding today’s offering: In no way is the following, or The Baric Files series in general in Health Friday posts, to be construed as a “character assassination”, or as an “indictment”, or as any other type of attack or smear on Ralph S. Baric, PhD, of the UNC Gillings School of Global Public Health of the University of North Carolina, Chapel Hill, or of his lab at the university. The linked scientific papers, images therefrom, and other information about Dr. Baric (such as his Curriculum Vitae [1]) are all available on the internet. The ideas and conclusions of today’s offering are by Yours Truly. There is a plethora of items related to Dr. Baric; Yours Truly will focus on some of them in each part of The Baric Files.

Special Note regarding Part Four through Part Six of The Baric Files: Starting with Part Four, the research journey of Dr. Ralph Baric, PhD, becomes more complex. What began in Part One with research into the Sindbis virus becomes more like an “octopus with many tentacles” by Part Four. Yours Truly will present some of the more important aspects of the now-augmented research journey of Dr. Baric. Please bear with me. Thank you.

Today’s offering is Part Four of six.

The Baric Files, Part Four: EcoHealth Alliance; Wuhan Institute of Virology; Dr. Zheng-li Shi; the “Template Patent”

To “lay the groundwork” for The Baric Files, Part Four, it is necessary to first make a slight “detour” regarding two things: the ACE2 receptor cells of the human body; and, the increasing focus of Dr. Baric’s experiments with SARS-CoV coronaviruses after the year 2002. Both are important components in his research journey.

The ACE2 receptor cells of the human body: The following article by Sriram, et al., from May 2020 discusses these cells [2]. Please see the screenshots from this article, below:

In his research journey, Dr. Baric performed experiments with ACE2 cells, and also produced review / analysis papers regarding ACE2 cells. One example is a 2009 paper by Baric and Graham [3] which discusses recombination experiments (which may be otherwise known as Gain-of-Function experiments) of the spike protein of coronaviruses and “cross-species transmission.” Please see the screenshots from this paper, below:

An example of the increasing work with SARS-CoV viruses: In his research journey, Dr. Baric also performed Gain-of-Function experiments with lung cells (which also included mention of shedding of the SARS-CoV virus via infected lung ciliated cells). An example of this work is a 2004 paper from Baric, et al. [4]. This paper was funded by the NIH. Please see the screenshots from this paper, below:

Ciliated cells in the lungs are cells that have tiny “hair-like” protrusions (cilia) that, among other functions, help to remove mucus.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Now, on to EcoHealth Alliance and the Wuhan Institute of Virology:

These entities were funded, in part, by NIH / NIAID: either, to disperse funds to other research entities (via EcoHealth Alliance); or, direct funding to other research entities for Gain-of-Function work (Wuhan Institute of Virology; the Baric lab at the UNC Gillings School of Global Public Health.) These funds were to be used for performing Gain-of-Function experiments on coronaviruses. In 2018, the DEFUSE proposal by EcoHealth Alliance, which was presented to the United States Defense Department, specifically mentions the roles that Dr. Ralph Baric (at UNC) and that Dr. Zheng-li Shi (of the Wuhan Institute of Virology) would play [5]. Please see the screenshots below from the proposal; first, the Title page:

From Page one:

From Page two:

From Page four:

From Pages five and six:

One more item needs to be mentioned: SHC014. This “SARS-like coronavirus” infects horseshoe bats. It was discovered in Yunnan Province in Communist China. Please keep WIV1 and SHC014 in mind while reading on.

In Yours Truly’s opinion, the DEFUSE proposal reads like a “blueprint” for a kind of elaborate “grant funds-laundering plus experiment-laundering” scheme under the aegis of EcoHealth Alliance. The Defense Department did not pursue the proposal. Instead, it appears that NIH / NIAID stepped in and provided funding for both Dr. Baric and for Dr. Shi via EcoHealth Alliance. For example, the NIAID issued a statement in October 2021 regarding that agency’s awarding grant R01AI110964 for experiments leading to the lab-creation of SARS-CoV-2 to the Wuhan Institute of Virology [6]. Please see the screenshot from this statement, below:

Both the United States General Accounting Office (GAO) and USA Spending have documented the R01AI110964 award grant by NIAID to EcoHealth Alliance to be dispersed to the Wuhan Institute of Virology {7}, [8]. Notwithstanding the NIAID statement above, the agency used taxpayer money to help fund the lab-creation of SARS-CoV-2 via experiments performed at the Wuhan Institute of Virology — and used what appears to be a “grant funding-laundering” scheme to do this. Please see the screenshots below; the first, from the GAO report; the second, from the USA Spending report:

After the NIH / NIAID was caught funding Wuhan University and the Wuhan Institute of Virology (WIV), the NIH grant R01AI110964 was terminated in 2022, with NIH citing “non-compliance” by the WIV in certain reporting areas [9].

However, it appears that Dr. Ralph Baric was one of the United States-based persons also using funds from R01AI110964. He, along with his co-authors (United States-based and overseas-based) collaborated on a paper, published on 3 September 2020, regarding the potential for SARS-CoV-2 “spillover” to wildlife [10].

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Dr. Zheng-li Shi

It appears that Dr. Ralph Baric had an exchange with Dr. Zheng-li Shi in 2013 at a conference [11]. It may be assumed that he had already known about her experiments with the SHC014 bat coronavirus. He asked her to send him some samples of this virus, which she did. Please the screenshots below from the above article:

It was after the 2013 exchange between Dr. Baric and Dr. Shi that the R01AI110964 grant was authorized in 2014 for SARS-CoV research at multiple facilities, including the Baric lab at UNC and at the Wuhan Institute of Virology (see above in today’s offering.)

It is interesting to note that EcoHealth Alliance (with, it appears, the consent and/or knowledge of Dr. Baric) was misleading the United States Defense Department regarding the DEFUSE Proposal that EcoHealth Alliance presented in 2018 [12]. It appears that EcoHealth was going to “emphasize” the United States portion of the SARS-CoV research that DEFUSE would fund, and “minimize” the involvement of Dr. Shi and the Wuhan institute of Virology. Please see the screenshots below from this article:

Dr. Zheng-li Shi denies ever actually working with Dr. Baric at his lab at UNC; instead, she sent the SHC014 samples and collaborated with Dr. Baric via other means (possibly, emails; written documents; and so on.) However, since Dr. Shi works at the Wuhan Institute of Virology (which itself is under the aegis of the Communist Chinese Peoples Liberation Army), it can perhaps be mentioned that “the truth is up for grabs” in this situation. These questions also arise: Were the students or others working at Dr. Baric’s lab who were from Communist China? If there were, is it possible that they were “information conduits” to persons working at the Wuhan Institute of Virology? Please see the screenshot from the True Story Award article by Jane Qiu [13] in February 2022, below:

Nonetheless, Dr. Shi and Dr. Baric were co-authors of the 2015 paper [14] which describes a “SARS-like cluster” of bat coronaviruses that could infect humans through zoonotic “leap “. This paper is sometimes cited as the “start of the SARS-CoV-2 virus.” Please see the screenshots from this paper, below; first, the Abstract; followed by two portions of the Main section; and, ending with the Acknowledgements:

The above 2015 Baric, Shi, et al., paper is Gain-of-Function on the SHC014 CoV bat coronavirus in order to render this virus possible to infect humans.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The “Template Patent”

The 2015 Baric, Shi, et al., paper above was published on 9 November 2015. This would assume at least six months of work, data collection and analysis, writing the paper and submitting it for peer-review, and so on, prior to publication. The paper was submitted on 12 June 2015 and accepted on 8 October 2015.

However, Dr. Baric was also working on something else before the November 2015 paper: what appears to be the “Template Patent” for the SARS-CoV-2 virus.

The following are screenshots from US Patent 9884895B2 granted to Ralph Baric, et al., via the University of North Carolina Chapel Hill on 18 October 2016. This Patent was applied for by Dr. Baric, et al., on 20 March 2015.[15] Please see the screenshots from the Patent document, below: first, the Patent Title and US Patent Number listing; second, the Invention and timeline section; third, the general Description; fourth, from the Detailed Description of the Invention (examples: the continuous mention of the use of the 2b subdivision of SARS-CoV viruses in the lab-creation (chimeric creation) of the possible SARS-CoV-2 virus “template”, including SHC014 and WIV1; the use of the Venezuela Equine Encephalitis virus in the lab-creation of the possible SARS-CoV-2 virus “template”; the use of Virus-like Particles in the lab-creation of the possible SARS-CoV-2 virus “template”; fifth, descriptions of methods to treat, prevent, and/or protect against an infection by this lab-created chimeric virus; sixth, from the Examples section regarding the development of a “vaccine” against an infection of such a virus; and, several figures from the Patent document.

It is interesting to note in the above screenshot the language regarding the lab-creation of a potentially lethal virus under BSL2 laboratory conditions.

Fig. 2 from the Patent: the S1/S2 site:

Fig. 6 from the Patent: graphic of the chimeric spike:

Fig. 10 from the Patent: the chimeric spike with the Venezuela Equine Encephalitis added:

Yours Truly: the above last screenshot regarding “methods” for treatment / prevention / protection against, an infection by this possible SARS-CoV-2 “template virus”, reads like a possible “list of basic ingredients” for products such as the modRNA COVID-19 “vaccines” [by Pfizer-BioNTech and by Moderna]; and also the “inactivated protein subunit” COVID-19 “vaccine” [by Novavax].

Several questions arise: First, did Dr. Ralph Baric share with Dr. Zheng-li Shi any of the work involved leading up to the application for US Patent 9884895B2? Second, did NIH share any information from US Patent 9884895B2 with Pfizer-BioNTech, or Moderna, or the United States Defense Department, or all of these, after the Patent was assigned to NIH in May 2017? Third, exactly to whom at NIH was the Patent assigned in May 2017? Fourth, exactly who at NIH holds the Patent assignment currently,especially since the Patent is in force until the year 2035? Fifth, was any information that Dr. Baric may have shared with Dr. Shi involved in the “lab leak”/ intentional release, of the SARS-CoV-2 virus from the Wuhan Institute of Virology lab in late 2019?

Thus far, it appears that the research journey of Dr. Ralph Baric, PhD, has progressed from the study of a mosquito-borne virus, to experiments with swine coronaviruses, to experiments with SARS-coronaviruses of various types, to the lab-creation of the “template virus” for SARS-CoV-2, to the Patent for the “Template Virus” for SARS-CoV-2; a Patent which also describes “methods” to treat, prevent, or to protect against infection, of such virus. It is Yours Truly’s opinion that, while the SARS-CoV-2 virus that was released into the world in late 2019 emanated from the lab of Dr. Zheng-li Shi at the Wuhan Institute of Virology, the “template” for this virus was very likely constructed in the lab of Dr. Ralph Baric, PhD, at the University of North Carolina Chapel Hill, and a United States Patent for this “template virus” was issued to Dr. Baric in 2016..

To be continued in Part Five.

THE COVID-19 “VACCINES” — ALL OF THEM — MUST BE REMOVED FROM THE MARKET AND FROM USE IN THE UNITED STATES. NOW.

THERE. MUST. BE. ACCOUNTABILITY.

THERE. MUST. BE. JUSTICE.

THERE. MUST. BE. TRUTH.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Notice and Disclaimer: With the exception of items above in today’s offering that are available online, the ideas and conclusions of today’s offering are by PAVACA. Proper credit must be given to PAVACA if ideas and conclusions of today’s offering are used by other blog writers, by podcasters, on social media, or in print media.)

References:

[1]: “Curriculum Vitae Ralph Baric.” https://sph.unc.edu/wp-content/uploads/sites/112/2016/09/CV_Ralph_Baric.pdf. 2016.

[2]: “What is the ACE2 receptor?” Krishna Sriram, Paul Insel, Rohit Loomba. https://www.asbmb.org/asbmb-today/science/051620/what-is-the-ace-2-receptor. 16 May 2020.

[3]: “Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission.” Rachel L Graham, Ralph S Baric. https://pmc.ncbi.nlm.nih.gov/articles/PMC2838128/. 11 November 2009.

[4]: “Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs.” Amy C. Sims, Ralph S. Baric, Boyd Yount, Susan E. Burkett, Peter L. Collins, Raymond J. Pickles. https://pmc.ncbi.nlm.nih.gov/articles/PMC1316022/. December 2005.

[5]: “Project DEFUSE: Defusing the Thread of Bat-borne Coronaviruses.” Peter Daszak, Ralph Baric, et al. https://www.documentcloud.org/documents/21066966-defuse-proposal/. 2018.

[6]: SARS-CoV-2 and NIAID-supported Bat Coronavirus Research.” https://www.niaid.nih.gov/diseases-conditions/coronavirus-bat-research. “Content last reviewed on October 20, 2021.” “EXP. DATE: 07/31/2028.”

[7]: “FEDERAL RESEARCH: NIH Could Take Additional Actions to Manage Risks Involving Foreign Subrecipients.” https://www.gao.gov/assets/gao-23-106119.pdf. 14 June 2023.

[8]: “R01AI110964.” https://www.usaspending.gov/award/ASST_NON_R01AI110964_7529.

[9]: Letter from Department of Health and Human Services to EcoHealth Alliance, Inc. https://oversight.house.gov/wp-content/uploads/2022/08/NIH-EHA-Production-8.19.22.pdf. 19 August 2022.

[10]: “Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats.” Ralph S. Baric, Peter Daszak, Lin-Fa Wang, et al. https://doi.org/10.1371/journal.ppat.1008758. 3 September 2020.

[11]: “Inside the risky bat-virus engineering that links America to Wuhan.” Rowan Jacobsen. https://www.congress.gov/117/meeting/house/114658/documents/HHRG-117-IF14-2022042. 29 June 2021.

[12]: “American scientists misled Pentagon on research at the Wuhan Institute of Virology.” Emily Kopp. https://usrtk.org/covid-19-origins/american-scientists-misled-pentagon-on-wuhan-research/. 18 December 2023.

[13]: “Meet the Scientist at the Center of the COVID Lab Leak Controversy.” https://truestoryaward.org/story/313. Jane Qiu. 9 February 2022.

[14]: “A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.” Ralph S. Baric, Zheng-li Shi, et al. https://doi.org/10.1038/nm.3985. Published 9 November 2015.

[15]: “Methods and compositions for chimeric coronavirus spike proteins.” Ralph Baric, Sudhakar Agnihothram, Boyd Yount. https://patents.google.com/patent/US9884895B2. Patent Application submitted, 3 March 2015. Patent Assigned to The University of North Carolina at Chapel Hill, 18 October 2016.

Health Friday 1.2.2026 Open Thread: The Baric Files, Part Three: Patents; Dr. Anthony Fauci

The header image of drawings for a Patent application is courtesy of Getty Images, ThoughtCo, and Google Images.

Health Friday is a series devoted to information about Big Pharma, general health, and associated topics. As today’s offering speaks to the disaster of COVID-19, Yours Truly dedicates it to all persons, of whatever age or location, who have suffered health issues from to an infection of the COVID-19 virus itself; or, from the negative effects of the COVID-19 “vaccines” that they have in their bodies; or, who have passed away from complications due to an infection of the COVID-19 virus itself, or from complications due to the negative effects of the COVID-19 “vaccines” they had in their bodies.

There are Important Notifications from our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. Note: Yours Truly has checked today’s offering for AI-generated content. To the best of her knowledge and belief, there is none, except for AI-generated images and/or text within linked URLs. If readers wish to post AI-generated content to today’s discussion thread, they must cite their source. Thank you.

Yours Truly wishes one and all a Happy New Year 2026.

Special Note regarding today’s offering: In no way is the following, or The Baric Files in general in the Health Friday posts, to be construed as a “character assassination”, or as an “indictment”, or as any other type of attack or smear on the Ralph Baric, PhD, of the UNC Gillings School of Global Public Health of the University of North Carolina, Chapel Hill, or of his lab at the university. The linked scientific papers, images therefrom, and other information about Dr. Baric (such as, his Curriculum Vitae [1]) are all available on the internet. The ideas and conclusions of today’s offering are by Yours Truly. There is a plethora of information related to Dr. Baric; Yours Truly will focus on a few of them in each part of The Baric Files.

Today’s offering is Part Three of six. For other information regarding Dr. Baric, please see: https://www.theqtree.com/2025/12/05/health-friday-12-5-2025-open-thread-the-baric-files-part-one/; and, https://www.theqtree.com/2025/12/12/heatlh-friday-12-12-2025-open-thread-the-baric-files-part-two-of-mice-rabbits-and-ai-23946/.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

The Baric Files, Part Three: Patents; Dr. Anthony Fauci

Patents:

Ralph S. Baric, PhD, owns 25 to 30 Patents (depending on whether one is looking at, for example, https://justia.com/patents/, or at https://patents.google.com/, or at NIH RePorter at https://report.nih.gov/) related to items he found or created during his research journey into coronaviruses and/or his Gain-of-Function experiments. What is definite, however, is that our old friend, NIH grant AI23946 (also called AI023946) figures in at least three of these Patents: Patent Number 6593111; Patent Number 7279327; and, Patent Number 7618802 — all of which are associated with his lab the UNC Gillings School of Global Public Health at the University of North Carolina Chapel Hill.

Patent Number 6593111 is titled, “Directional assembly of large viral genomes and chromosomes.”

Patent Number 7279327 is titled, “Methods of Producing Recombinant Coronaviruses.”

Patent Number 7618802 is titled, “Methods and compositions for infectious cDNA of SARS coronavirus.”

Yours Truly will focus on Patent Number 6593111 [2], the timeline of which Patent begins on 5 May 2001. The NIH grant AI023946 has been “extended” several times; in this Patent, it is called “AI023946-08“, and the Patent Number has been changed to “US6593111B2.” By now, Dr. Baric’s research journey has taken him to experimenting with coronaviruses that infect pigs: in particular, the TGE virus (Transmissible Gastroenteritis virus, also called Transmissible Gastroenteritis Coronavirus [TGEV].) The following screenshots are from the Patent document. The screenshots are, in order: the Abstract; the Events summary; the first paragraph of the Summary of the Invention section; from the Detailed Description of the Preferred Embodiments discussion section; and, Fig. 1a and Fig. 2 from the images in the Patent document:

Note, in the screenshot above, the mention of “vaccines and expression vectors”; and, the sentence, “The vectors may be targeted to other species by, for example, replacing the S glycoprotein gene.” This paragraph, in Yours Truly’s’ opinion, begins the eventual “tie-into evolution” of the SARS-CoV-2 virus. In other words — Gain-of-Function research and application.

However, there is another item in Patent Number US6593111B2 that is interesting: the list of Legal Events near the end of the document. A screenshot of this list is below:

Note that UNC (Baric lab) “transferred” the ownership of the Patent to the NIH in 2008. Note also that on 18 January 2011, someone at NIH must have sent the Patent Fee payment that would be good for eight years. A Fee payment for a Patent is a “Patent Maintenance Fee” that “preserve a patent.” [3] Note also, that on 15 January 2015, someone at NIH must have sent the Patent Fee payment that would good for twelve years (thus theoretically preserving the Patent until January 2027.) However, on the Events Summary list for Patent Number US6593111B2 (in the images above), it lists the Patent as Status Expired – Lifetime. This brings up some questions: To what person at NIH was Patent US6593111 transferred to in 2008? The NIH Director in June 2008 was Elias Zerhouni, MD [4]. When he left the NIH, who did he designate to take over NIH ownership of the Patent? Is Patent US6593111B2 still in force, even though it is listed as “Status Expired – Lifetime?” Is it still in force, but under a different name?

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Anthony Fauci, MD, Director of NIAID 1984 – 2022:

It can be assumed that Dr. Ralph Baric, PhD, had been on the “radar” of Dr. Anthony Fauci, MD, Director of the NIAID division (National Institute of Allergy and Infectious Diseases division) of the National Institutes of Health (NIH) since at least 1984, if not before (Dr. Fauci had joined NIH in 1968, shortly after completing his medical Residency.) This “being on his radar” situation, in Yours Truly’s opinion, would have included, at the least, what may be called a “bowing acquaintance” with Dr. Baric through NIAID funding applications and grants dispersements reports.

In fact, NIH / NIAID (and, it can be assumed, within the knowledge of Dr. Anthony Fauci), was funding Dr. Barics’s Gain-of-Function research on coronaviruses as far back as at least the year 2003 [5]. The 2003 paper not only describes what can only be called Gain-of-Function experiments with SARS coronaviruses; it also describes the Baric-invented “No see ‘m” procedure for covering up gene code insertions in the lab-creation of SARS coronavirus “clone” viruses. Please see the screenshots from this paper, below. Note that our old friend, NIH grant AI23946, was involved in the funding of the 2003 paper. Below are: the Abstract, the Figure 1., and, the Acknowledgements sections from this paper:

Note that one of the co-authors of the 2003 paper is Thomas M. Geisbert, of the the United States Army Medical Research Institute of Infectious Diseases (also known as USAMRIID, located at Fort Detrick, Maryland.)

Another example of NIH / NIAID / Dr. Anthony Fauci funding Gain-of-Function research by Dr. Baric is NIH grant R01AI059136-04, from 2004 [6]. Please see the screenshots from the documents on this grant, below: of the Title for the grant; the Abstract; the Funding Agency; and, the receiving Institution:

Dr. Fauci has denied ever knowing Dr. Baric. However, there is evidence to the opposite: Please see the screenshots, below, from a February 2023 U.S. Right to Know article by Emily Kopp [7]:

A screenshot of a photo from the Emily Kopp article:

The official work calendar for Dr. Anthony Fauci was released via FOIA from Open The Books [8]. The calendar shows that Dr. Fauci met with Dr. Baric in February 2020. A screenshot from the article in Open The Books on this situation is below:

An article by Sainath Suryanarayanan in U.S. Right to Know related to Dr. Baric’s emails early in the COVID-19 pandemic [9]. These emails were either from Dr. Baric, or were sent to him as part of a group email from various institutions and/or government agencies and/or from medical professionals in these institutions or agencies. In these emails, the “code name” for the burgeoning COVID-19 virus infection situation in the United States was “Red Dawn Responding, Start 16 March.” The emails were released through a public records request.

By the way, Dr. Baric and his lab at the University of North Carolina Chapel Hill worked with Gilead Sciences to create remdesivir (Veklury), a COVID-19 treatment drug that can have a mortality rate of 50%, and also can cause kidney damage [10] [11] [12] [13]. Please see the screenshots below; the first, from the University of North Carolina article about the creation of remdesivir; the others are also items regarding this drug:

Please see Reference [10].

Veklury Package Insert,Warnings and Precautions:

Please see Reference [11].

Please see Reference [12].

World Health Organization (WHO) advisory against using Veklury (remdesivir):

Please see Reference [13].

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

It is apparent that by at least the year 2003, Dr. Baric’s research journey was shifting to methods and applications for the cloning of coronaviruses, including his invention of the “No see ‘m” method of covering up insertions into coronavirus gene code pieces in the lab-creation of the cloning of coronaviruses to make such insertions “un-traceable.”

To be continued in The Baric Files: Part Four.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

ALL COVID-19 “VACCINES” MUST BE REMOVED FROM THE MARKET AND FROM USE IN THE UNITED STATES. NOW.

ALL GAIN-OF-FUNCTION RESEARCH ACTIVITIES IN THE UNITED STATES MUST BE STOPPED AND DE-FUNDED. NOW.

THERE. MUST. BE. ACCOUNTABILITY.

THERE. MUST. BE. JUSTICE.

THERE. MUST. BE. TRUTH.

Peace, Good Energy, Respect: PAVACA

(Intellectual Property Notice and Disclaimer: With the exception of published scientific papers, news articles, and other items available on the internet, the ideas and conclusions of today’s offering are by PAVACA. Proper credit must be given to PAVACA if the ideas and conclusions in today’s offering are used by other blog writers, podcasters, in social media, or in print media.)

References:

[1]: “Curriculum Vitae Ralph S. Baric”. https://sph.unc.edu/wp-content/uploads/sites/112/2016/09/CV_Ralph_Baric.pdf. 2016.

[2]: “Directional Assembly Of Coronavirus Infectious Clones”. https://patents.google.com/patent/US6593111B2/en. Ralph S. Baric, Boyd Yount.

[3]: “Patent Maintenance Fees – Must be paid to preserve a patent.” https://sierraiplaw.com/patent-maintenance-fees, 2023 Sierra IP.

[4]: “Elias Zerhouni.” https://en.wikipedia.org/wiki/Elias_Zerhouni.

[5]: “Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.” https://www.pnas.org/cgi/doi/10.1073/pnas.1735582100. Ralph S. Baric, Thomas Geisbert, et al. 29 August 2003.

[6]: “SARS Reverse Genetics.” https://grantome.com/grant/NIH/R01-AI059136-04.

[7]: US Right to Know. https://usrtk.org/covid-19-origins/fauci-discussed-gain-of-function-work-with-wuhan-collaborator-in-pandemics-earliest-days-emails-suggest/. Emily Kopp. 21 February 2023.

[8]: Open the Books. https://www.openthebooks.com/substack-historic-release-dr-anthony-faucis-official-work-calendar-november-2019-march-2020/. Adam Andrzejewski. 20 October 2022.

[9]: US Right to Know. “Items from coronavirus expert Ralph Baric’s emails.” https://usrtk.org/covid-19-origins/ralph-baric-emails/. Sainath Suryanarayanan. 14 December 2020.

[10]: “Remdesivir developed through a UNC-Chapel Hill partnership proves effective against COVID-19 in NIAID human clinical trials.” https://sph.unc.edu/sph-news/remdesivir-developed-at-unc-chapel-hill-proves-effective-against-covid-19-in-niaid-human-clinical-trials/. 29 April 2020.

[11]: “Veklury Package Insert.” https://www.gilead.com/-/media/files/pdfs/medicines/covid-19/veklury/veklury_pi.pdf. Veklury is the marketing name for remdesivir.

[12]: “BREAKING — The Pandemic Justice Phase Begins as Criminal Investigations Commence.” https://www.thefocalpoints.com/p/breaking-the-pandemic-justice-phase. Nicolas Hulscher. 18 April 2025.

[13]: “FDA Approves Remdesivir in Kidney Patients after Failed Trial.” https://www.thefocalpoints.com/p/fda-approves-remdesivir-in-kidney. Dr. Peter A. McCullough, MD, MPH. 21 July 2023.